Fred Hutch leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
https://www.fredhutch.org/en/news/releases/2022/12/Xiao_Unger_COVIDclinicaltrials.html
Fred Hutch leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
Meta-analysis of 122 COVID-19 clinical trials cites need for strategies to address trial participation gaps
SEATTLE December 5, 2022
Women were underrepresented in COVID-19 treatment clinical trials, and some racial and ethnic groups were underrepresented in COVID-19 prevention trials, according to a new meta-analysis conducted by Fred Hutchinson Cancer Center in collaboration with researchers from Beijing and London.
The study, published in JAMA Internal Medicine, identified system-wide differences in representation among several key demographic groups in COVID-19 prevention and treatment trials in the U.S.
To our knowledge, this is the first study to comprehensively examine demographic representation across the landscape of both COVID-19 prevention and treatment trials over the first two years of this pandemic, said Hong Xiao, PhD, researcher in the Public Health Sciences Division at Fred Hutch and the lead author for the study.
more
Fred Hutchinson Cancer Center is an independent organization that serves as UW Medicine's cancer program. (University of Washington Seattle WA)